GSK-GLP110933

Study Sponsor: GSK

Study Title

Study 110933: Albiglutide versus Placebo in insulin-treated Subjects with new-onset type 1 diabetes mellitus

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

GLP110933

Trial Registry Identification Number(#'s)

NCT02284009 2014-001825-33

Medical Condition

Diabetes Mellitus, Type 1

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The data for this study is available in CDISC format.

Date Added to this Site

May 2020